Search

Your search keyword '"Marras, F."' showing total 87 results

Search Constraints

Start Over You searched for: Author "Marras, F." Remove constraint Author: "Marras, F."
87 results on '"Marras, F."'

Search Results

54. Paracelsin E, a new peptaibol from Trichoderma saturnisporum

55. Congenital hip dysplasia: The importance of early screening and treatment.

56. A comparative analysis of unintegrated HIV-1 DNA measurement as a potential biomarker of the cellular reservoir in the blood of patients controlling and non-controlling viral replication.

58. Control of the HIV-1 DNA Reservoir Is Associated In Vivo and In Vitro with NKp46/NKp30 (CD335 CD337) Inducibility and Interferon Gamma Production by Transcriptionally Unique NK Cells.

59. Natural Killer Cell Development and Maturation Revisited: Possible Implications of a Novel Distinct Lin - CD34 + DNAM-1 bright CXCR4 + Cell Progenitor.

60. Activating Killer Immunoglobulin Receptors and HLA-C: a successful combination providing HIV-1 control.

61. Analysis of NK Cell Function and Receptor Expression During HTLV-1 and HTLV-2 Infection.

62. 'Emergency exit' of bone-marrow-resident CD34(+)DNAM-1(bright)CXCR4(+)-committed lymphoid precursors during chronic infection and inflammation.

63. Dissecting metabolic syndrome components: data from an epidemiologic survey in a genetic isolate.

64. Inherent transcriptional signatures of NK cells are associated with response to IFNα + rivabirin therapy in patients with Hepatitis C Virus.

65. Sports-related changes of the synovial membrane.

66. Relationship between innate immunity, soluble markers and metabolic-clinical parameters in HIV+ patients ART treated with HIV-RNA<50 cp/mL.

67. Baseline and Dynamic Expression of Activating NK Cell Receptors in the Control of Chronic Viral Infections: The Paradigm of HIV-1 and HCV.

68. Immunology of tuberculosis.

69. Natural killer cells in HIV controller patients express an activated effector phenotype and do not up-regulate NKp44 on IL-2 stimulation.

70. Successfully treated HIV-infected patients have differential expression of NK cell receptors (NKp46 and NKp30) according to AIDS status at presentation.

71. Natural killer cells in hepatitis C virus infection.

72. Receptor modulation and functional activation of human CD34+ Lin- -derived immature NK cells in vitro by Mycobacterium bovis Bacillus Calmette-Guerin (BCG).

73. Activating NK cell receptor expression/function (NKp30, NKp46, DNAM-1) during chronic viraemic HCV infection is associated with the outcome of combined treatment.

74. Reverse-flow adsorption for process-integrated recycling of homogeneous transition-metal catalysts.

75. Involvement of activating NK cell receptors and their modulation in pathogen immunity.

78. Genetic architecture of hand quantitative ultrasound measures: a population-based study in a Sardinian genetic isolate.

79. High resolution analysis and phylogenetic network construction using complete mtDNA sequences in sardinian genetic isolates.

80. Viridenepoxydiol, a new pentasubstituted oxiranyldecene produced by Trichoderma viride.

81. Browsing isolated population data.

82. [One-year therapy with dihydroergocristine for treatment of impaired alertness and memory in elderly patients. Placebo-controlled multicenter study].

83. [Study of the tolerability and effectiveness of a new sleep-inducing preparation].

84. [Efficacy and tolerability of imidazole-2-hydroxybenzoate and feprazone in the treatment of some diseases of the respiratory tract].

85. Therapeutic usefulness of a corticosteroid, antibacterial and antifungal combination in skin diseases of various origins.

87. [Heterogeneity of human circulating lymphocytes].

Catalog

Books, media, physical & digital resources